Lymphatic Filariasis: Clinical Trials

3 trials for Lymphatic Filariasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 withdrawn. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 2, Withdrawn 1

Follow Lymphatic Filariasis: new trials by email Literature Review of Lymphatic Filariasis trials Research Report on Lymphatic Filariasis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Twice Yearly Treatment for the Control of LF
400 μg/kg Ivermectin + 400 mg Albendazole - Lymphatic Filariasis, Helminth Infection
Phase 4CompletedNoguchi Memorial Institute for Medical Research14622017-05-192020-02-26
Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic Filariasis
azithromycin, ivermectin, albendazole - Trachoma, Lymphatic Filariasis
Phase 4WithdrawnEmory University2014-02-012014-05-22
Impact of Albendazole -Ivermectin on Wuchereria Bancrofti in Mali
''albendazole'' and ''ivermectin'' - Lymphatic Filariasis
Phase 4CompletedCentre d'Appui à la lutte contre la Maladie11392001-05-012016-05-27

Narrower conditions

Elephantiasis, Filarial (3)  ·  Neglected Diseases (1)  ·  Trachoma (1)  ·  Trematode Infections (1)

Broader conditions

Filariasis (3)  ·  Helminthiasis (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Infections (3)  ·  Lymphatic Diseases (3)  ·  Lymphedema (3)  ·  Mosquito-Borne Diseases (3)  ·  Nematode Infections (3)  ·  Parasitic Diseases (3)  ·  Secernentea Infections (3)  ·  Spirurida Infections (3)  ·  Vector Borne Diseases (3)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Chlamydia Infections (1)

Interventions

Albendazole (3)  ·  Ivermectin (3)  ·  Azithromycin (1)

Sponsors

Centre d'Appui à la lutte contre la Maladie (1)  ·  Emory University (1)  ·  Noguchi Memorial Institute for Medical Research (1)

Countries

Ghana (1)  ·  Mozambique (1)

Top investigators

Dziedzom K de Souza, PhD (1)  ·  Huub C Gelderblom, MD, PhD, MPH (1)  ·  Ricardo Thompson, PhD (1)

Results publications

PMID 23981378, PMID 28969715